Andrea Sbrana

967 total citations
52 papers, 452 citations indexed

About

Andrea Sbrana is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Andrea Sbrana has authored 52 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 21 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Andrea Sbrana's work include Cancer Immunotherapy and Biomarkers (10 papers), Renal cell carcinoma treatment (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Andrea Sbrana is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Renal cell carcinoma treatment (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Andrea Sbrana collaborates with scholars based in Italy, United States and France. Andrea Sbrana's co-authors include Andrea Antonuzzo, Alfredo Falcone, Luca Galli, Marco Danova, Lodovico Balducci, Carla Ripamonti, Tracy A. Balboni, Christina M. Puchalski, Anne Vandenhoeck and Betty Ferrell and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry and Annals of Oncology.

In The Last Decade

Andrea Sbrana

49 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Sbrana Italy 12 144 106 80 80 74 52 452
Peter Busch Østergren Denmark 14 136 0.9× 152 1.4× 187 2.3× 47 0.6× 128 1.7× 52 911
William Xu New Zealand 15 81 0.6× 84 0.8× 306 3.8× 70 0.9× 29 0.4× 65 812
Verna Lavender United Kingdom 9 93 0.6× 32 0.3× 43 0.5× 158 2.0× 37 0.5× 17 393
Xianhua Fu China 14 110 0.8× 59 0.6× 142 1.8× 24 0.3× 13 0.2× 29 607
Kate Webber Australia 15 404 2.8× 136 1.3× 66 0.8× 25 0.3× 88 1.2× 47 669
Adam Lowy Switzerland 16 241 1.7× 76 0.7× 193 2.4× 40 0.5× 32 0.4× 20 874
Nicholas Lao Canada 10 92 0.6× 41 0.4× 19 0.2× 115 1.4× 76 1.0× 18 353
Shuting Liang United States 14 156 1.1× 40 0.4× 232 2.9× 13 0.2× 56 0.8× 32 858
Su‐Jin Koh South Korea 16 227 1.6× 114 1.1× 121 1.5× 19 0.2× 254 3.4× 88 745
Sullivan United States 15 42 0.3× 60 0.6× 112 1.4× 40 0.5× 38 0.5× 38 571

Countries citing papers authored by Andrea Sbrana

Since Specialization
Citations

This map shows the geographic impact of Andrea Sbrana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Sbrana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Sbrana more than expected).

Fields of papers citing papers by Andrea Sbrana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Sbrana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Sbrana. The network helps show where Andrea Sbrana may publish in the future.

Co-authorship network of co-authors of Andrea Sbrana

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Sbrana. A scholar is included among the top collaborators of Andrea Sbrana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Sbrana. Andrea Sbrana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nieri, Dario, Alessandro Cipriano, Erica Bazzan, et al.. (2025). Circulating, Extracellular Vesicle-Associated Tissue Factor in Cancer Patients with and without Venous Thromboembolism. Biomolecules. 15(1). 83–83. 1 indexed citations
2.
Petrini, Iacopo, Stefania Crucitta, Andrea Sbrana, et al.. (2024). Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients. Translational Oncology. 52. 102228–102228. 2 indexed citations
3.
Camerini, Andrea, Francesca Mazzoni, Vieri Scotti, et al.. (2024). Efficacy and Safety of Chemotherapy after Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer. Journal of Clinical Medicine. 13(13). 3642–3642. 3 indexed citations
4.
Bruno, Rossella, Anello Marcello Poma, Carmelina Cristina Zirafa, et al.. (2024). Early-Stage Non-Small Cell Lung Cancer: Prevalence of Actionable Alterations in a Monocentric Consecutive Cohort. Cancers. 16(7). 1410–1410. 5 indexed citations
5.
Tourneau, Christophe Le, Massimo Ghiani, M.C. Cau, et al.. (2023). First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE. Cancer Reports. 6(5). e1804–e1804. 4 indexed citations
6.
Feo, Giulia De, Amy A. Case, Gregory B. Crawford, et al.. (2023). Multinational Association of Supportive Care in Cancer (MASCC) guidelines: cannabis for psychological symptoms including insomnia, anxiety, and depression. Supportive Care in Cancer. 31(3). 176–176. 13 indexed citations
7.
Guadagni, Simone, Andrea Peri, Matteo Palmeri, et al.. (2023). Surgical treatment of recurrent retroperitoneal sarcoma in its different patterns: A 15-years’ two-centers experience. The Surgeon. 21(5). e249–e257.
8.
Davis, Mellar P., Andrea Sbrana, David Hui, et al.. (2023). MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events. Supportive Care in Cancer. 31(4). 202–202. 21 indexed citations
9.
Sbrana, Andrea, Marco Ferrari, Giulia Massaro, et al.. (2022). Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis. Vaccines. 10(6). 892–892. 1 indexed citations
10.
Hui, David, Sandip Mukhopadhyay, Carole Bouleuc, et al.. (2022). Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer. Supportive Care in Cancer. 31(1). 39–39. 17 indexed citations
11.
Sbrana, Andrea, Andrea Antonuzzo, Carla Ripamonti, et al.. (2022). Efficacy of a nurse monitoring service at preventing disease- or therapy-related symptoms in patients receiving targeted therapy or immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). 12118–12118. 1 indexed citations
12.
Palmeri, Matteo, Gregorio Di Franco, Matteo Bianchini, et al.. (2021). Prognostic impact of conservative surgery for pancreatic IPMNs. Surgical Oncology. 38. 101582–101582. 6 indexed citations
13.
Sbrana, Andrea, Francesco Bloise, Elena Sammarco, et al.. (2020). 1711P SARS-CoV-2 infection in prostate cancer patients: Data from a high-incidence area in Italy. Annals of Oncology. 31. S1007–S1007. 2 indexed citations
14.
Dalise, Stefania, Peppino Tropea, Luca Galli, Andrea Sbrana, & Carmelo Chisari. (2020). Muscle function impairment in cancer patients in pre-cachexia stage.. PubMed. 30(2). 8931–8931. 6 indexed citations
15.
Puchalski, Christina M., Andrea Sbrana, Betty Ferrell, et al.. (2019). Interprofessional spiritual care in oncology: a literature review. ESMO Open. 4(1). e000465–e000465. 77 indexed citations
16.
Sbrana, Andrea, Andrea Antonuzzo, Luca Galli, et al.. (2018). A case of a patient with severe renal failure on hemodialysis treated with vismodegib for relapsing basal cell carcinoma. Tumori Journal. 104(6). NP2–NP4. 2 indexed citations
17.
Sbrana, Andrea, Elisa Biasco, Claudia Caserta, et al.. (2018). Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience. Anticancer Research. 38(8). 4913–4918. 3 indexed citations
18.
Re, Marzia Del, Elisa Biasco, Stefania Crucitta, et al.. (2016). AR-V7 detection in plasma-derived exosomal RNA strongly predicts resistance to hormonal therapy in metastatic prostate cancer. Annals of Oncology. 27. vi248–vi248. 1 indexed citations
19.
Sbrana, Andrea, et al.. (2016). Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy. Annals of Oncology. 27. vi101–vi101. 2 indexed citations
20.
Antonuzzo, Andrea, Paolo Bossi, Laura Botta, et al.. (2016). Systematic review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy. Annals of Oncology. 27. iv110–iv110.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Busch Østergren Breakdown of academic impact, for papers by William Xu Breakdown of academic impact, for papers by Verna Lavender Breakdown of academic impact, for papers by Xianhua Fu Breakdown of academic impact, for papers by Kate Webber Breakdown of academic impact, for papers by Adam Lowy Breakdown of academic impact, for papers by Nicholas Lao Breakdown of academic impact, for papers by Shuting Liang Breakdown of academic impact, for papers by Su‐Jin Koh Breakdown of academic impact, for papers by Sullivan
Rankless by CCL
2026